Prevention by cromakalim of spontaneously occurring cardiac necroses in polymyopathic hamsters

Cardiovascular Drugs and Therapy

Volumn 10, Issue 5, 1996, Pages 587-591

  Jasmin, Gaëtan ^a   Proschek, Libuse ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardioprotection; Cromakalim; Hamster cardiomyopathy; K+(ATP) channels

Indexed keywords

CALCIUM ION; CROMAKALIM; DIMETHYL SULFOXIDE; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIAPHRAGM; FEMALE; HAMSTER; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART VENTRICLE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; TONGUE;

ANIMALS; BENZOPYRANS; CARDIOMYOPATHIES; CREATINE KINASE; CRICETINAE; CROMAKALIM; FEMALE; MALE; MYOCARDIUM; NECROSIS; PARASYMPATHOLYTICS; POTASSIUM CHANNELS; PYRROLES;

EID: 0029859776     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051001     Document Type: Article

References (34)

1. Jasmin G, Proschek L. The hamster cardiomyopathy: New insights in the pathogenesis of this hereditary disease. In: Bkaily G, ed. Membrane Physiopathology. Boston: Kluwer Academic Publishers; 1994:2-11.
2. Wagner JA, Reynolds LJ, Weisman HF, Dudeck P, Weisfeldt M, Snyder SH. Calcium antagonist receptors in cardiomyopathic hamster: Selective increase in heart muscle and brain. Science 1986;232:515-518.
3. Hewlett SE, Gordon T. Calcium channels in normal and dystrophic hamster cardiac muscle. Biochem Pharmacol 1987;36:2653-2659.
4. Sapp JL, Howlett SE. Density of ryanodine receptors is increased in sarcoplasmic reticulum from prehypertrophic cardiomyopathic hamster heart. J Mol Cell Cardiol 1994; 26:325-334.
5. Wrogemann K, Pena SDJ. Mitochondrial calcium overload: A general mechanism of cell-necrosis in muscle diseases. Lancet 1976;1:672-674.
6. Jasmin G, Bajusz E. Polymyopathic et cardiomyopathie héréditaire chez le hamster de Syrie. Ann Anat Pathol 1973;18:49-66.
7. Jasmin G, Proschek L. Pathogenesis of the hamster hereditary cardiomyopathy. A pharmacologic appraisal. In: Kawai C, Abelman WH, eds. Pathogenesis of Myocarditis and Cardiomyopathy. Tokyo; University of Tokyo Press 1987: 79-89.
8. Jasmin G, Proschek L. The paradoxical effect of isoproterenol on hamster hereditary polymyopathy. Muscle Nerve 1983;6:408-415.
9. + channels in cardiac muscle. Nature 1983;305:147-148.
10. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-581.
11. Grover GJ. Protective effects of ATP sensitive potassium channel openers in models of myocardial ischaemia. Cardiovasc Res 1994;26:778-782.
12. Spruce AE, Standen NB, Stanfield PR. Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane. Nature 1985;316:736-738.
13. + channels in skeletal muscle by intracellular protons. Nature 1990;343: 375-377.
14. e sensitivity. Pflügers Arch 1989;414(Suppl 1):S88-S92.
15. + channel openers and "natural" cardioprotection. Trends Pharmacol Sci 1992;13(Suppl): 269-272.
16. + channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sci 1990;47:1693-1705.
17. Mallory FB. Von Kossa's method for calcium. In: Pathological Technique. New York: Hafner, 1961:144.
18. Abascus Concepts. Stat View. Berkley, CA: Abascus Concepts, 1992:343-351.
19. Wikman-Coffelt J, Sievers R, Parmley WW, Jasmin G. Cardiomyopathic and healthy acidotic hamsters hearts: Mitochondrial activity may regulate cardiac performance. Cardiovasc Res 1986;20:471-481.
20. Quast U. Potassium channel openers: Pharmacological and clinical aspects. Fundam Clin Pharmacol 1992;6:279-293.
21. Cavero I, Djellas Y, Guillon JM. Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels. Cardiovasc Drugs Ther 1995;9:245-255.
22. Jiang C, Mochizuki S, Poole-Wilson PA, Harding SE, Mac-Leod KT. Effect of lemakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes. Cardiovasc Res 1994;28:851-857.
23. Bkaily G. Single heart cells as models to study cardiac toxicolocy. In: Jolles G, Cordier A, eds. In Vitro Methods in Toxicology. New York: Academic Press, 1992:289-334.
24. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994;75:149-155.
25. Proschek L, Jasmin G. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic changes in relation to defective mitochondrial function. Muscle Nerve 1982;5:26-32.
26. Opie LH. Modulation of ischemia by regulation of the ATP-sensitive potassium channel. Cardiovasc Drugs Ther 1993; 7:507-513.
27. Jasmin G, Bajusz E. Prevention of myocardial degeneration in hamsters with hereditary cardiomyopathy. In: Fleckenstein A, Rona G, eds. Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 6. Baltimore: University Park Press, 1975:219-229.
28. Factor SM, Minase T, Cho S, Dominitz R, Sonnenblick EH. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circ Res 1982;66:342-354.
29. Kajioka S, Nakashima M, Kitamura K, Kuriyama H. Mechanisms of vasodilatation induced by potassium-channel activators. Clin Sci 1991;81:129-139.
30. Kassler DP, Cates AE, Van Dop C, Feldman AM. Decreased bioactivity of guanidine nucleotide-binding protein that stimulates adenylate cyclase in hearts from cardiomyopathic Syrian hamsters. J Clin Invest 1989;84:244-252.
31. Cantin M, Forthomme D, Bajusz E. Renal glomerulus in experimental congestive heart failure: Ultrastructural and functional study. In: Bajusz E, Rona G, Brink AJ, Lochner A, eds. Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 2. Baltimore: University Park Press, 1973:467-492.
32. Spuler A, Lehmann-Horn F, Grafe P. Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres. Naunyn Schmiedebergs Arch Pharmacol 1989;339:327-331.
33. + conductance in human skeletal muscle fibres. Pflügers Arch 1989;414(Suppl 1):S179-S180.
34. Ludin HP. Microelectrode study of dystrophic human skeletal muscle. Eur Neurol 1970;3:116-121.